Piotr Rieske

1.7k total citations
88 papers, 1.3k citations indexed

About

Piotr Rieske is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Piotr Rieske has authored 88 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 30 papers in Genetics and 26 papers in Oncology. Recurrent topics in Piotr Rieske's work include Glioma Diagnosis and Treatment (26 papers), Cancer-related Molecular Pathways (11 papers) and Cancer Genomics and Diagnostics (10 papers). Piotr Rieske is often cited by papers focused on Glioma Diagnosis and Treatment (26 papers), Cancer-related Molecular Pathways (11 papers) and Cancer Genomics and Diagnostics (10 papers). Piotr Rieske collaborates with scholars based in Poland, United States and Germany. Piotr Rieske's co-authors include Ewelina Stoczyńska-Fidelus, Sylwester Piaskowski, Paweł P. Liberski, Barbara Krynska, Małgorzata Szybka, S. Ausim Azizi, Dawid P. Grzela, Dariusz J. Jaskólski, Maciej Walczak and Jacek Bartkowiak and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Piotr Rieske

83 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Piotr Rieske Poland 21 680 361 312 255 127 88 1.3k
Sílvia Regina Caminada de Toledo Brazil 23 654 1.0× 333 0.9× 290 0.9× 287 1.1× 113 0.9× 68 1.4k
H. J. Altermatt Switzerland 17 562 0.8× 285 0.8× 274 0.9× 143 0.6× 174 1.4× 38 1.2k
Paula Yeng Po Lam Singapore 19 927 1.4× 401 1.1× 419 1.3× 309 1.2× 46 0.4× 49 1.6k
Raymund L. Yong United States 17 600 0.9× 469 1.3× 230 0.7× 258 1.0× 90 0.7× 48 1.2k
Yiquan Ke China 26 1.1k 1.7× 397 1.1× 273 0.9× 701 2.7× 98 0.8× 100 2.0k
Maria Laura Falchetti Italy 26 664 1.0× 447 1.2× 266 0.9× 233 0.9× 53 0.4× 49 1.5k
Angela Bentivegna Italy 21 724 1.1× 445 1.2× 243 0.8× 275 1.1× 59 0.5× 57 1.4k
John C. Sok United States 13 819 1.2× 187 0.5× 401 1.3× 136 0.5× 240 1.9× 15 1.5k
Elena Birman Canada 20 809 1.2× 645 1.8× 325 1.0× 279 1.1× 38 0.3× 33 1.7k
И. В. Холоденко Russia 18 467 0.7× 213 0.6× 226 0.7× 140 0.5× 209 1.6× 51 945

Countries citing papers authored by Piotr Rieske

Since Specialization
Citations

This map shows the geographic impact of Piotr Rieske's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piotr Rieske with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piotr Rieske more than expected).

Fields of papers citing papers by Piotr Rieske

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piotr Rieske. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piotr Rieske. The network helps show where Piotr Rieske may publish in the future.

Co-authorship network of co-authors of Piotr Rieske

This figure shows the co-authorship network connecting the top 25 collaborators of Piotr Rieske. A scholar is included among the top collaborators of Piotr Rieske based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piotr Rieske. Piotr Rieske is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rieske, Piotr, et al.. (2024). The hope, hype and obstacles surrounding cell therapy. Journal of Cellular and Molecular Medicine. 28(10). e18359–e18359. 1 indexed citations
2.
Rieske, Piotr, et al.. (2024). Regulation of CAR transgene expression to design semiautonomous CAR-T. SHILAP Revista de lepidopterología. 32(3). 200833–200833.
3.
Stoczyńska-Fidelus, Ewelina, et al.. (2023). Increased EGFRvIII Epitope Accessibility after Tyrosine Kinase Inhibitor Treatment of Glioblastoma Cells Creates More Opportunities for Immunotherapy. International Journal of Molecular Sciences. 24(5). 4350–4350. 6 indexed citations
4.
Jesionek‐Kupnicka, Dorota, et al.. (2023). Immunohistochemical detection of EGFRvIII in glioblastoma – Anti-EGFRvIII antibody validation for diagnostic and CAR-T purposes. Biochemical and Biophysical Research Communications. 685. 149133–149133. 2 indexed citations
5.
Stoczyńska-Fidelus, Ewelina & Piotr Rieske. (2022). Assessment of COVID-19 vaccination effectiveness. 9(1). 1–13.
6.
7.
Kuljanin, Miljan, Ewelina Stoczyńska-Fidelus, Bartłomiej Pawlik, et al.. (2022). Proteomic and Transcriptomic Landscapes of Alström and Bardet–Biedl Syndromes. Genes. 13(12). 2370–2370. 6 indexed citations
8.
Rieske, Piotr, et al.. (2022). Phenotypical Flexibility of the EGFRvIII-Positive Glioblastoma Cell Line and the Multidirectional Influence of TGFβ and EGF on These Cells—EGFRvIII Appears as a Weak Oncogene. International Journal of Molecular Sciences. 23(20). 12129–12129. 4 indexed citations
9.
Stoczyńska-Fidelus, Ewelina, et al.. (2022). Regeneration difficulties in patients with FQAD can limit the use of iPSc-based cell therapy. Stem Cell Research & Therapy. 13(1). 210–210. 1 indexed citations
10.
Rieske, Piotr, et al.. (2016). Praktyczne aspekty zastosowania chityny i jej pochodnych w leczeniu ran. Chemik. 70. 1 indexed citations
11.
Popęda, Marta, Magdalena Książkiewicz, Dawid P. Grzela, et al.. (2016). EGFR Activation Leads to Cell Death Independent of PI3K/AKT/mTOR in an AD293 Cell Line. PLoS ONE. 11(5). e0155230–e0155230. 30 indexed citations
12.
Popęda, Marta, et al.. (2016). Efficient and simple approach toin vitroculture of primary epithelial cancer cells. Bioscience Reports. 36(6). 22 indexed citations
13.
Stoczyńska-Fidelus, Ewelina, et al.. (2014). Different mutational characteristics of TSG in cell lines and surgical specimens. Tumor Biology. 35(11). 11311–11318. 2 indexed citations
14.
Bieńkowski, Michał, Sylwester Piaskowski, Ewelina Stoczyńska-Fidelus, et al.. (2013). Screening for EGFR Amplifications with a Novel Method and Their Significance for the Outcome of Glioblastoma Patients. PLoS ONE. 8(6). e65444–e65444. 30 indexed citations
15.
Stoczyńska-Fidelus, Ewelina, Małgorzata Szybka, Sylwester Piaskowski, et al.. (2011). Limited importance of the dominant-negative effect of TP53missense mutations. BMC Cancer. 11(1). 243–243. 7 indexed citations
16.
17.
Pietruszewska, Wioletta, et al.. (2009). Loss of heterozygosity for Rb locus and pRb immunostaining in laryngeal cancer: a clinicopathologic, molecular and immunohistochemical study.. Folia Histochemica et Cytobiologica. 46(4). 479–85. 4 indexed citations
18.
Zakrzewska, Magdalena, Małgorzata Szybka, Krzysztof Zakrzewski, et al.. (2007). Diverse molecular pattern in a bihemispheric glioblastoma (butterfly glioma) in a 16-year-old boy. Cancer Genetics and Cytogenetics. 177(2). 125–130. 10 indexed citations
19.
Zawlik, Izabela, Magdalena Zakrzewska, Ewa Golańska, et al.. (2006). KCTD11 expression in medulloblastoma is lower than in adult cerebellum and higher than in neural stem cells. Cancer Genetics and Cytogenetics. 170(1). 24–28. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sílvia Regina Caminada de Toledo Breakdown of academic impact, for papers by H. J. Altermatt Breakdown of academic impact, for papers by Paula Yeng Po Lam Breakdown of academic impact, for papers by Raymund L. Yong Breakdown of academic impact, for papers by Yiquan Ke Breakdown of academic impact, for papers by Maria Laura Falchetti Breakdown of academic impact, for papers by Angela Bentivegna Breakdown of academic impact, for papers by John C. Sok Breakdown of academic impact, for papers by Elena Birman Breakdown of academic impact, for papers by И. В. Холоденко
Rankless by CCL
2026